02/16/2016 | 3008058540 | Infupharma LLC dba President Pharmacy | Closeout Letter | FL | Compounding Pharmacy | 10/03/2016 |
12/11/2015 | 3002468086 | Unique Pharmaceuticals Ltd. | Closeout Letter | TX | Outsourcing Facility | 10/03/2016 |
06/12/2016 | 3004955246 | Western Drug, Inc. dba Western Drug and General Store | Closeout Letter | AZ | Compounding Pharmacy | 10/03/2016 |
08/31/2016 | 3002815949 | Stokes Healthcare Inc. dba Stokes Pharmacy | Closeout Letter | NJ | Producer of Sterile Drug Products | 10/03/2016 |
Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary Compounding Law; Health Care; Awareness of all Types of Compounding Issues; Pharmacy Benefit Managers (PBMs), Outsourcing Facilities Food and Drug Administration and Compliance Issues
Monday, October 3, 2016
Using New Drug Cocktail, Ohio Seeks To Resume Death Penalty
NPR-2 hours ago
That led to shortages, so states turned to new drugs made by compoundingpharmacies, which do not face the same kind of approval process that big ...
IA-66-40 | Detention Without Physical Examination of Drugs From Firms Which Have Not Met Drug GMPs | http://www.accessdata.fda.gov/ |
IA-66-41 | Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S. | http://www.accessdata.fda.gov/ |
Now it's personal: Top execs made to pay for companies' false claims
Last year, U.S. Deputy Attorney General Sally Quillian Yates warned top healthcare executives they would be held personally accountable for false Medicare and Medicaid claims and illegal physician relationships. She was serious. READ MORE
Subscribe to:
Posts (Atom)